没有数据	没有数据

没有数据	没有数据

来源	SDS样本
Alfa-Aesar	浏览或下载
TCI	浏览或下载
Oakwood	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents.Gergely Horváth et al.Neurobiology of disease, 70, 162-178 (2014-06-28) Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.K E Kristensen et al.Clinical pharmacology and therapeutics, 96(6), 713-722 (2014-09-16) The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping.Taimour Y Langaee et al.Pharmacogenetics and genomics, 24(8), 381-386 (2014-06-20) Dual antiplatelet therapy in acute transient ischemic attack and minor stroke.Graeme J Hankey The New England journal of medicine, 369(1), 82-83 (2013-06-28) [Effect of aspirin plus clopidogrel therapy on aspirin resistance after off-pump coronary artery bypass surgery].Xue-zhong Wang et al.Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 35(5), 495-502 (2013-11-05) Impact of clopidogrel response on the clinical evolution in patients with acute coronary syndromes.Irina Iuliana Costache et al.Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 116(4), 962-967 (2013-05-25) Effect of diammonium glycyrrhizinate on pharmacokinetics of omeprazole by regulating cytochrome P450 enzymes and plasma protein binding rate.Lu Han et al.Xenobiotica; the fate of foreign compounds in biological systems, 49(8), 975-980 (2018-09-15) Risk of intracranial injury after minor head trauma in patients with pre-injury use of clopidogrel.Michael Levine et al.The American journal of emergency medicine, 32(1), 71-74 (2013-10-15) Safer heart-attack prevention for seniors with revised drug regimen. Half the normal dose of prasugrel, a lifesaving medication, is just as effective as the larger dose, and reduces risk of serious side effects. DukeMedicine healthnews, 19(11), 1-2 (2014-03-13) Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trial.Willibald Hochholzer et al.Journal of the American College of Cardiology, 64(4), 361-368 (2014-07-26) Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.Gregg W Stone et al.Lancet (London, England), 382(9892), 614-623 (2013-07-31) Special Care Dentistry: Part 2. dental management of patients with drug-related acquired bleeding disorders.Najla Nizarali et al.Dental update, 40(9), 711-712 (2014-01-07) Extending the indications of flow diversion to small, unruptured, saccular aneurysms of the anterior circulation.Nohra Chalouhi et al.Stroke, 45(1), 54-58 (2013-11-21) In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome.Dimitrios Alexopoulos et al.American heart journal, 167(1), 68-76 (2013-12-18) Pharmacogenetics and cardiovascular disease--implications for personalized medicine.Julie A Johnson et al.Pharmacological reviews, 65(3), 987-1009 (2013-05-21) [Thrombocyte aggregation inhibitors: what are the risks?].Ivanka Curkovic et al.Praxis, 102(20), 1243-1250 (2013-10-04) Ticlopidine hydrochloride.P A Blissitt The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 24(5), 296-300 (1992-10-01) Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis.Matej Samoš et al.The American journal of emergency medicine, 32(5), 461-465 (2014-02-25) [Secondary prevention with clopidogrel after TIA or stroke].S M Yvonne Zuurbier et al.Nederlands tijdschrift voor geneeskunde, 157(25), A5836-A5836 (2013-06-20) The net clinical benefit of personalized antiplatelet therapy in patients undergoing percutaneous coronary intervention.Jolanta M Siller-Matula et al.Clinical science (London, England : 1979), 128(2), 121-130 (2014-08-16) Characterization of ticlopidine-induced developmental and teratogenic defects in Xenopus embryos and human endothelial cells.Park SM, et al. Chemico-Biological Interactions, 240, 172-178 (2015) Aortic thrombosis secondary to clopidogrel-related thrombotic thrombocytopenic purpura.Giulio Cavalli et al.British journal of haematology, 166(4), 470-470 (2014-06-10) Antiplatelet therapy and anticoagulants - authors' reply.Willem J M Dewilde et al.Lancet (London, England), 382(9886), 25-25 (2013-07-09) Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement.Laurent Feldman et al.American heart journal, 168(6), 940-947 (2014-12-03) Repeat head computed tomography in anticoagulated traumatic brain injury patients: still warranted.Bellal Joseph et al.The American surgeon, 80(1), 43-47 (2014-01-10) Ask the doctors. I recently had a drug-eluting stent placed in one of my coronary arteries after an episode of severe chest pain. My doctor told me I had to take Plavix every day. Now I feel perfectly fine-except for my right hip. I need a hip replacement, but my orthopedist wants to wait until I'm off Plavix before operating. How long is long enough to be on this drug?Thomas Lee et al.Harvard heart letter : from Harvard Medical School, 23(6), 2-2 (2013-07-19) The chronovariability of platelet reactivity: a hurdle in the road to personalized antiplatelet therapy?Ori Ben-Yehuda Journal of the American College of Cardiology, 64(4), 369-371 (2014-07-26) [What kind of antiplatelet treatment in acute coronary syndrome?--Intensive antiplatelet treatment only for patients with invasive strategy].Thomas Meinertz Deutsche medizinische Wochenschrift (1946), 138(45), 2288-2288 (2013-10-29) Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.Hrvoje Gasparovic et al.The American journal of cardiology, 113(10), 1660-1667 (2014-03-29) Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.Stephen D Wiviott et al.Lancet (London, England), 382(9892), 605-613 (2013-08-21) Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?Michelle T Harrison et al.Thorax, 69(7), 609-615 (2014-04-20) ACP Journal Club. Adding clopidogrel to aspirin after TIA or minor ischemic stroke reduced stroke without increasing bleeding.Michael D Hill Annals of internal medicine, 159(8), JC5-JC5 (2013-10-16) Dual antiplatelet therapy after drug-eluting stents--how long to treat?Antonio Colombo et al.The New England journal of medicine, 371(23), 2225-2226 (2014-11-18) Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.Pierluigi Tricoci et al.American heart journal, 168(6), 869-877 (2014-12-03) Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.Lesly A Pearce et al.The Lancet. Neurology, 13(12), 1177-1185 (2014-12-03) Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.Morten Lamberts et al.Circulation, 129(15), 1577-1585 (2014-01-29) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.Yongjun Wang et al.The New England journal of medicine, 369(1), 11-19 (2013-06-28) Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy.Brad S Karon et al.Clinical chemistry, 60(12), 1524-1531 (2014-10-05) Hidden implications: potential antiplatelet effects of adjuvant anaesthetic agents.R A Callender et al.Anaesthesia and intensive care, 41(4), 550-551 (2013-07-03) Clopidogrel in infants with systemic-to-pulmonary-artery shunts.David L Wessel et al.The New England journal of medicine, 368(25), 2377-2384 (2013-06-21) The consult guys--balancing the medication portfolio 5 years after a heart attack.Geno J Merli et al.Annals of internal medicine, 161(12), CG12-CG12 (2014-12-17) Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.Mathieu Pankert et al.The American journal of cardiology, 113(1), 54-59 (2013-11-05) ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR.Deborah B Diercks et al.The American journal of emergency medicine, 31(7), 1005-1011 (2013-05-25) Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.Soraya Mezouar et al.International journal of cancer, 136(2), 462-475 (2014-06-04) Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.A Tornio et al.Clinical pharmacology and therapeutics, 96(4), 498-507 (2014-06-28) Effect of clopidogrel use post coronary artery bypass surgery on graft patency.Ramin Ebrahimi et al.The Annals of thoracic surgery, 97(1), 15-21 (2013-11-12) Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention.Fabio Mangiacapra et al.The American journal of cardiology, 113(7), 1124-1129 (2014-02-11) US lawyers investigate trial that secured license for AstraZeneca's antiplatelet drug.Deborah Cohen BMJ (Clinical research ed.), 347, f6727-f6727 (2013-11-12) Identification of human cytochrome P450 isozymes involved in the metabolism of naftopidil enantiomers in vitro.Lijun Zhu et al.The Journal of pharmacy and pharmacology, 66(11), 1534-1551 (2014-06-20) Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial).Sorin J Brener et al.The American journal of cardiology, 113(9), 1457-1460 (2014-03-19) Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.C Picard-Fraire Thrombosis research. Supplement, 4, 119-128 (1983-01-01) [Not Available].H S Füessl MMW Fortschritte der Medizin, 155(19), 32-32 (2014-01-31) Antiplatelet therapy and anticoagulants.Bartosz Hudzik et al.Lancet (London, England), 382(9886), 24-24 (2013-07-09) Smoking status and the effects of antiplatelet drugs.Michael M Hirschl BMJ (Clinical research ed.), 347, f5909-f5909 (2014-01-30) Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management.Ghassan Zaid et al.The Israel Medical Association journal : IMAJ, 15(12), 775-776 (2014-01-24) Frequency and outcomes of concomitant use of proton pump inhibitors and clopidogrel after hospital discharge.Pedro Mas-Morey et al.Therapie, 68(2), 113-115 (2013-06-19) Effect of platelet inhibition on bleeding complications in trauma patients on preinjury clopidogrel.Shannon Short et al.The journal of trauma and acute care surgery, 74(6), 1419-1424 (2013-05-23) Use of antiplatelet agents in patients with atherosclerotic disease.Subasit Acharji et al.Postgraduate medicine, 125(5), 19-30 (2013-10-12) Blood pressure control after stroke: too little, too late, or too soon to tell?Argye E Hillis The Lancet. Neurology, 13(12), 1162-1163 (2014-12-03) Mechanisms of chronic fialuridine hepatotoxicity as revealed in primary human hepatocyte spheroids.Delilah F G Hendriks et al.Toxicological sciences : an official journal of the Society of Toxicology (2019-09-11) Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.Colin P Derdeyn et al.Lancet (London, England), 383(9914), 333-341 (2013-10-31) Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.Stavros Spiliopoulos et al.Expert opinion on pharmacotherapy, 15(15), 2205-2217 (2014-08-28) Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.Baolei Guo et al.Journal of vascular surgery, 60(4), 993-1001 (2014-06-01) The importance of genotype variation beyond different antiplatelet therapy in nonresponder patients.Gennaro Sardella et al.Journal of the American College of Cardiology, 64(3), 333-334 (2014-07-19) Reply: The importance of genotype variation beyond different antiplatelet therapy in nonresponder patients.Dániel Aradi et al.Journal of the American College of Cardiology, 64(3), 334-334 (2014-07-19) Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy.Paul W Armstrong et al.The American journal of medicine, 126(8), 723-729 (2013-06-26) Incidence of intracranial hemorrhage and outcomes after ground-level falls in geriatric trauma patients taking preinjury anticoagulants and antiplatelet agents.Subhash Reddy et al.The American surgeon, 80(10), 975-978 (2014-09-30) Efficacy of contemporary medical management for asymptomatic carotid artery stenosis.Jason Chang et al.The American surgeon, 79(10), 987-991 (2013-10-29) LOAD: a pilot study of the safety of loading of aspirin & clopidogrel in acute ischaemic stroke and transient ischaemic attack. Is the loading dose of aspirin and clopidogrel a good alternative for patients with acute ischaemic stroke and TIA? How this will impact our clinical practice?Fauzia Nomani et al.JPMA. The Journal of the Pakistan Medical Association, 63(10), 1316-1316 (2014-01-08) P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation.Edvard Galić et al.Collegium antropologicum, 37(2), 491-498 (2013-08-15) Platelet inhibition with cangrelor during PCI.Deepak L Bhatt et al.The New England journal of medicine, 369(4), 393-394 (2013-07-26) High on-clopidogrel treatment platelet reactivity in Thai patients with chronic stable angina scheduled for percutaneous coronary intervention.Rewat Phankingthongkum et al.Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 96(5), 538-543 (2013-06-12) Dual antiplatelet therapy after stent implantation.Stephen J Greene et al.JAMA, 311(14), 1446-1446 (2014-04-10) [Clopidogrel plus acetylsalicylic acid: a deadly combination].Gerard A Rongen Nederlands tijdschrift voor geneeskunde, 157(25), A6221-A6221 (2013-06-20) Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits?Luis Alejandro Asencio et al.The American journal of medicine, 127(7), 579-585 (2014-03-13) Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies.Jennifer L Gordon et al.The journal of trauma and acute care surgery, 75(3), 475-486 (2013-10-04) Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]).Peter Damman et al.The American journal of cardiology, 113(1), 64-69 (2013-10-31) Antiplatelet and anticoagulation therapy in microlaryngeal surgery.David O Francis et al.The Laryngoscope, 124(4), 928-934 (2013-08-16) [It is possible to reduce drug-drug interactions. Interactions were corrected frequently by patient-specific letters to general practitioners].Olof Cronberg et al.Lakartidningen, 110(48), 2176-2177 (2014-01-18) Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.Fausto Feres et al.JAMA, 310(23), 2510-2522 (2013-11-02) Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.Jan H Cornel et al.American heart journal, 168(1), 76-87 (2014-06-24) Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy.M Janzon et al.Heart (British Cardiac Society), 101(2), 119-125 (2014-09-18) Early dual therapy for Chinese adults with TIA. BMJ (Clinical research ed.), 347, f4197-f4197 (2013-07-05) Reply: To PMID 23891491.Carlos Saadeh et al.Journal of vascular surgery, 59(5), 1475-1476 (2014-04-29) Generic clopidogrel: time to substitute?Jacob Doll et al.JAMA, 310(2), 145-146 (2013-07-11) CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.Thomas O Bergmeijer et al.American heart journal, 168(1), 16-22 (2014-06-24) Resistance to antiplatelet drugs: what progress has been made?Udaya S Tantry et al.Expert opinion on pharmacotherapy, 15(17), 2553-2564 (2014-10-10) Effect of scutellarin on the metabolism and pharmacokinetics of clopidogrel in rats.Xinmeng Chen et al.Biopharmaceutics & drug disposition, 36(1), 64-68 (2014-09-27) Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting.Bum Joon Kim et al.Journal of neurosurgery, 121(4), 891-898 (2014-07-19) Prehospital ticagrelor in ST-segment elevation myocardial infarction.Gilles Montalescot et al.The New England journal of medicine, 371(11), 1016-1027 (2014-09-02) Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.Stavros Spiliopoulos et al.Expert opinion on pharmacotherapy, 15(15), 2205-2217 (2014-08-28) Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.Baolei Guo et al.Journal of vascular surgery, 60(4), 993-1001 (2014-06-01) Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.K Anette Fiedler et al.American heart journal, 167(4), 459-465 (2014-03-25) [Interview with the Daiichi-Sankyo managing director Ralf Göddertz (interview by Dirk Einecke and Cornelius Heyer)].Ralf Göddertz MMW Fortschritte der Medizin, 155(7), 16-16 (2013-05-15) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.Laura Mauri et al.The New England journal of medicine, 371(23), 2155-2166 (2014-11-18) Platelet function assays--not all are created equal.Wayne L Chandler Clinical chemistry, 60(12), 1469-1470 (2014-10-22) [Differentiated antiplatelet therapy for acute coronary syndromes].A Schäfer et al.Deutsche medizinische Wochenschrift (1946), 139(4), 152-158 (2014-01-17) Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trial.Lars-Åke Levin et al.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 16(4), 574-580 (2013-06-26) Should clopidogrel be discontinued before laparoscopic cholecystectomy?Katherine Anderson et al.American journal of surgery, 208(6), 926-931 (2014-12-02) Clopidogrel use as a risk factor for poor outcomes after kidney transplantation.Jennifer M Williams et al.American journal of surgery, 208(4), 556-562 (2014-09-23) Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis.Christopher Cao et al.The Journal of thoracic and cardiovascular surgery, 148(6), 3092-3098 (2014-06-24) TRILOGY ACS: prasugrel of benefit only after angiography?Rajesh V Swaminathan et al.Lancet (London, England), 382(9892), 580-582 (2013-08-21)

备注